This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
CHANGE IN RATINGSBiomarin(BMRN - Get Report) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Risk/reward is no longer compelling at current levels. $45 price target.
Energy Partners(BKEP) downgraded to sell at TheStreet Ratings.
Chiquita Brands(CQB) downgraded to sell at TheStreet Ratings.
Globus Medical(GMED) rated new Outperform at William Blair. Company can gain market share and deliver above-average annual sales growth.
LyondellBasell(LYB) downgraded at UBS from Buy to Neutral, UBS said. $49 price target. Company could be hurt by rising ethane prices.
Public Service(PEG) downgraded at FBR to Underperform, FBR Capital Markets said. Valuation call, based on a $30 price target.
Treehouse(THS) upgraded at Citigroup from Neutral to Buy, Citigroup said. $61 price target. Estimates also boosted, ahead of the private-label K-Cup launch.
Westlake Chemical(WLK) downgraded at UBS from Neutral to Sell, UBS said. Valuation call, based on a $54 price target.
Weyerhaeuser(WY) upgraded at BMO from Underperform to Market Perform, BMO Capital said. Company is leveraged to rising lumber and panel prices. $26.50 price target.
STOCK COMMENTS / EPS CHANGES
Apple(AAPL - Get Report) target raised at Oppenheimer to $800, according to Oppenheimer. Expect higher mini-iPad and iPhone sales. Outperform rating.
Advanced Micro(AMD) numbers reduced at Sterne Agee. Shares of AMD now seen reaching $6, according to Sterne Agee. Estimates also cut, given weaker consumer demand. Neutral rating.
Groupon(GRPN - Get Report) target reduced at Ascendiant to $3.50. Growth uncertainties and concerns remain. Sell rating.
Intel(INTC - Get Report) estimates reduced at JMP through 2013, JMP Securities said. Industry checks suggest weaker PC demand. Outperform rating and $33 price target.
Intel estimates, target cut at Citigroup. INTC estimates were reduced through 2013, Citigroup said. Company is likely to fall short of near-term earnings expectations. Buy rating and new $32 price target.
>To submit a news tip, email: